Federated Hermes, Inc. Johnson & Johnson Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,096,837 shares of JNJ stock, worth $321 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

2,096,837

Previous 1,126,519 86.13%

Holding current value

$321 Million

Previous $165 Million 106.38%

% of portfolio

0.78%

Previous 0.4%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$145.48 - $167.38 $141 Million - $162 Million	970,318 Added 86.13%	2,096,837 $340 Million
Q2 2024 Aug 08, 2024	BUY	$144.38 - $157.78 $46.4 Million - $50.7 Million	321,201 Added 39.88%	1,126,519 $165 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $3.41 Million - $3.57 Million	-21,942 Reduced 2.65%	805,318 $127 Million
Q4 2023 Jan 31, 2024	BUY	$145.6 - $158.88 $29.6 Million - $32.3 Million	203,378 Added 32.6%	827,260 $130 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $18.6 Million - $20.8 Million	-119,341 Reduced 16.06%	623,882 $97.2 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $801,693 - $862,775	5,194 Added 0.7%	743,223 $123 Million
Q1 2023 May 08, 2023	BUY	$151.05 - $180.26 $24.7 Million - $29.5 Million	163,449 Added 28.45%	738,029 $114 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $17.7 Million - $19.9 Million	110,423 Added 23.79%	574,580 $101 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $7.93 Million - $8.82 Million	-49,124 Reduced 9.57%	464,157 $75.8 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $24.2 Million - $26.8 Million	-143,826 Reduced 21.89%	513,281 $91.1 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $4.6 Million - $5.23 Million	29,095 Added 4.63%	657,107 $116 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $5.48 Million - $6.08 Million	35,154 Added 5.93%	628,012 $107 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $5.93 Million - $6.59 Million	-36,692 Reduced 5.83%	592,858 $95.7 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $7.8 Million - $8.37 Million	48,938 Added 8.43%	629,550 $104 Million
Q1 2021 May 13, 2021	BUY	$153.07 - $170.48 $11.5 Million - $12.8 Million	75,007 Added 14.84%	580,612 $95.4 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $626,729 - $719,383	4,571 Added 0.91%	505,605 $79.6 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $38.1 Million - $41.7 Million	-271,234 Reduced 35.12%	501,034 $74.6 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $11.8 Million - $14.3 Million	91,927 Added 13.51%	772,268 $109 Million
Q1 2020 May 13, 2020	BUY	$111.14 - $153.99 $14.6 Million - $20.2 Million	131,463 Added 23.95%	680,341 $89.2 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $3.27 Million - $3.76 Million	-25,656 Reduced 4.47%	548,878 $80.1 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $3.23 Million - $3.61 Million	-25,406 Reduced 4.23%	574,534 $74.3 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $670,176 - $737,066	-5,110 Reduced 0.84%	599,940 $83.6 Million
Q1 2019 May 10, 2019	SELL	$125.72 - $139.79 $7.35 Million - $8.17 Million	-58,455 Reduced 8.81%	605,050 $84.6 Million
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $20.5 Million - $24.7 Million	167,286 Added 33.71%	663,505 $85.6 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $24.7 Million - $29 Million	-203,132 Reduced 29.05%	496,219 $68.6 Million
Q2 2018 Aug 10, 2018	SELL	$119.4 - $131.76 $13.8 Million - $15.2 Million	-115,557 Reduced 14.18%	699,351 $84.9 Million
Q1 2018 May 09, 2018	BUY	$125.1 - $148.14 $39.1 Million - $46.3 Million	312,461 Added 62.19%	814,908 $104 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $36.3 Million - $39.7 Million	276,734 Added 122.6%	502,447 $0
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $29.2 Million - $30.6 Million	225,713	225,713 $29.3 Million

Others Institutions Holding JNJ

# of Institutions

4,270

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Johnson & Johnson Transaction History